ARTICLE | Clinical News
Exelon Patch rivastigmine neurology data
July 24, 2006 7:00 AM UTC
Data from the 6-month, double-blind, placebo-controlled, international IDEAL study in 1,195 patients showed that NVS's Exelon Patch led to significant improvements in memory versus placebo. Also, Exel...